ClinicalTrials.Veeva

Menu

The Effect of Curcumin Supplementation on Recovery From Exercise-induced Muscle Damage

S

St Mary's University College

Status

Unknown

Conditions

Exercise Induced Muscle Damage

Treatments

Dietary Supplement: Curcumin

Study type

Interventional

Funder types

Other

Identifiers

NCT05346211
ASE22HELCON

Details and patient eligibility

About

Recent evidence suggests that curcumin supplementation may reduce muscle inflammation, oxidative markers, and muscle damage. The most favourable dosage to elicit these ergogenic effects are yet to be established; both 750mg & 1500mg has been shown to be effective. Curcumin supplementation has been ingested in numerous different ways however, no previous research to date has used curcumin in a hydrolysed (drinkable) format. The aim of this study is to investigate whether hydrolysed curcumin can reduce indices of muscle damage and improve recovery, whilst also examining a potential dose-response effect.

Enrollment

36 estimated patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Inclusion criteria are as follows:

  • between the age of 18-35
  • non-smoker
  • no previous history of cardiovascular, respiratory, or neurological problems
  • not taking anticoagulant medication
  • injury-free in the 3 months prior to scheduled participation in the study

Exclusion criteria

Exclusion criteria include:

  • hypertension (<140/80)
  • any blood diseases or clotting issues,
  • injury, or previous injury in <3 months

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

36 participants in 3 patient groups

Curcumin Single
Experimental group
Description:
The Single dose group will consume 1 placebo sachet and one curcumin sachet per day. Curcumin supplementation will be from YourZooki, the supplement in question is commercially offered to the public in a tangerine flavour. The sachets will be in 750mg hydrolysed format. The placebo is a sachet containing the same ingredients mentioned above minus the curcumin. The sachets will be in 750mg hydrolysed format. Supplementation will be administered and commence 48-hours prior to the first testing day and will be consumed twice a day (8am \& 8pm).
Treatment:
Dietary Supplement: Curcumin
Curcumin Double
Experimental group
Description:
The double dose group will consume two sachets per day of curcumin. Curcumin supplementation will be from YourZooki, the supplement in question is commercially offered to the public in a tangerine flavour. The sachets will be in 750mg hydrolysed format. Supplementation will be administered and commence 48-hours prior to the first testing day and will be consumed twice a day (8am \& 8pm).
Treatment:
Dietary Supplement: Curcumin
Placebo
No Intervention group
Description:
Placebo sachets containing the same ingredients mentioned above minus the curcumin. The sachets will be in 750mg hydrolysed format. Participants will consume two sachets per day. Supplementation will be administered and commence 48-hours prior to the first testing day and will be consumed twice a day (8am \& 8pm).

Trial contacts and locations

0

Loading...

Central trial contact

Ian Grant, MSc; Luke Hughes, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems